Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00647556 · ClinicalTrials.gov registry record · Phase 3
Adapalene Gel 0.3% Versus Tretinoin 0.05% Emollient Cream for Treatment of Photodamage
A Phase 3 study of Photoaging, sponsored by Galderma R&D.
- Completed
- Registry status
- Phase 3
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT00647556 is a Phase 3 study of Photoaging that has completed, run by Galderma R&D. The registered enrollment target is 30 participants, roughly in line with the 30-participant average among 14 other Photoaging trials with a reported enrollment target. The trial reports 1 study location across 1 state.
The verdict
NCT00647556, a Phase 3 study of Photoaging, has completed, sponsored by Galderma R&D.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary purpose of this study is to compare the efficacy of adapalene (Differin®) gel 0.3% and tretinoin 0.05% emollient cream for the treatment of signs of photodamage, with tolerability assessment as a secondary objective.
Conditions Studied
Interventions
- DRUG adapalene gel, 0.3%
- DRUG tretinoin 0.05% emollient cream
Study Locations (1)
Michigan
- University of Michigan Department of Dermatology - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2008-04 |
| Est. Completion | 2010-01 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00647556
The ClinicalTrials.gov registry entry for NCT00647556 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 30-participant average among 14 other Photoaging trials with a reported enrollment target. The listed sponsor is Galderma R&D, which has 158 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Photoaging appearing as the primary indexed condition, and to 2 interventions - of which adapalene gel, 0.3% is the first listed.
NCT00647556 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.
Frequently Asked Questions
What is clinical trial NCT00647556 about?
NCT00647556 is a clinical study titled "Adapalene Gel 0.3% Versus Tretinoin 0.05% Emollient Cream for Treatment of Photodamage". The primary purpose of this study is to compare the efficacy of adapalene (Differin®) gel 0.3% and tretinoin 0.05% emollient cream for the treatment of signs of photodamage, with tolerability assessment as a secondary objective.
What is the current status of trial NCT00647556?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 30 participants. The study started on 2008-04. Estimated completion is 2010-01.
What conditions does trial NCT00647556 study?
This clinical trial studies the following conditions: Photoaging.
What interventions are being tested in trial NCT00647556?
The interventions under investigation include: adapalene gel, 0.3% (DRUG), tretinoin 0.05% emollient cream (DRUG).
Who is sponsoring clinical trial NCT00647556?
This trial is sponsored by Galderma R&D, which has 158 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00647556 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Photoaging
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Investigating Age Dependence of Fibroblast and Extracellular Matrix Responses to Cross-linked Hyaluronic Acid Filler in Human Skin
RECRUITING · NA
-
Evaluation of the Effects of a Biostimulator and Dermal Fillers for Cheek Augmentation and Contour Deficiencies
ACTIVE NOT RECRUITING · NA
-
Effect of Platelet Rich Plasma on Photoaged Skin
ACTIVE NOT RECRUITING · Phase 1
-
Evaluating Procedure Pairing of a Post-Procedure Cream Versus a Comparator in Patients Treated With a Radiofrequency Microneedling for Facial Rejuvenation
COMPLETED · NA
-
Comparison of the Cosmetic Effects of Bakuchiol and Retinol
COMPLETED · Early Phase 1
-
Double-Blind Study Determining the Efficacy of CannaXR in Decreasing UVA Premutagenic and Photoaging Markers
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.